Baker Bros. Investments, L.P. is Director & 10% Owner at GENOMIC HEALTH INC (GHDX). They have made 6 open-market trades across 1 company since 2019, most recently 2019-03-11.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GHDX | 8,903,498 | $564.8M |
Shares reported on the most recent Form 4, priced at the 2019-03-11 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | -1.4% | -11.4% | -30.4% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GHDX | SELL | 2019-03-07 | 2019-03-11 | $74.52 | $10.7M | -1.2% | -9.2% | -31.2% |
| GHDX | SELL | 2019-03-05 | 2019-03-05 | $77.04 | $754K | -1.3% | -11.7% | -30.3% |
| GHDX | SELL | 2019-03-04 | 2019-03-05 | $76.49 | $2.0M | -1.3% | -11.7% | -30.3% |
| GHDX | SELL | 2019-03-01 | 2019-03-05 | $77.02 | $9.0M | -1.3% | -11.7% | -30.3% |
| GHDX | SELL | 2019-03-01 | 2019-03-05 | $77.20 | $6.1M | -1.3% | -11.7% | -30.3% |
| GHDX | SELL | 2019-02-28 | 2019-02-28 | $76.20 | $46K | -1.9% | -12.5% | -30.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.